REQUEST A DEMO
Total
USD $0.00
Search more companies

Grownbury Pharmaceuticals Private Limited (India)

Main Activities: Basic Chemical Manufacturing
Full name: Grownbury Pharmaceuticals Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Grownbury Pharmaceuticals Private Limited is based in India. The head office is in Shahdara. The enterprise operates in the Basic Chemical Manufacturing industry. The company was established on December 18, 2009. There was a net sales revenue increase of 22.32% reported in Grownbury Pharmaceuticals Private Limited’s latest financial highlights for 2023. During that time, Grownbury Pharmaceuticals Private Limited’s total assets decreased by 23.09%. The net profit margin of Grownbury Pharmaceuticals Private Limited increased by 0.08% in 2023.

Legal Address
28, New Layal Pur Extn. Krishna Nagar
Shahdara; Delhi; Postal Code: 110051

Contact Details: Purchase the Grownbury Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Grownbury Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Grownbury Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
December 18, 2009
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
91.84%
Purchase this report to view the information.
8.16%
Company Performance
Financial values in the chart are available after Grownbury Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
22.32%
Total Operating Revenue
22.38%
Operating Profit
25.69%
EBITDA
25.23%
Net Profit/Loss for the Period
30.18%
Total Assets
-23.09%
Total Equity
32.5%
Operating Profit Margin
0.06%
Net Profit Margin
0.08%
Return on Equity (ROE)
-0.44%
Debt / Equity
-106%
Quick Ratio
-0.14%
Cash Ratio
-0.19%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?